Published in Drug Law Weekly, January 1st, 2008
"Impaired diabetic wound healing may be due to defective LM-332 mediated keratinocyte migration. To evaluate LM-332 expression in diabetic (db/db) and control (db/-) mice and to test LM-332 wound healing effects when applied to mouse wounds. LM-332 expression in mouse wounds was evaluated using immunohistochemistry. LM-332 wound healing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.